It has been a difficult period for investors in small cap biotech stocks, which have suffered a huge write down in the last year or so as these long duration assets have been adversely affected by the sharp increase in discount rates.
A round up of the day’s news brought to you by the team at small-cap broker and advisor Hybridan.
With interims next Monday, Mark Watson-Mitchell says that the shares are cheap trading at 6.7 times earnings.
A round up of the day’s news brought to you by the team at small-cap broker and advisor Hybridan.
As many as five million British workers have either taken early retirement since the pandemic or are on long-term sick leave. Is more immigration the solution? Or could the missing workers be enticed back to work? Victor Hill explores possible options.
Mark Watson-Mitchell catches up with the news on some of his favourite stocks ahead of the weekend.
A round up of the day’s news brought to you by the team at small-cap broker and advisor Hybridan.
A round up of the day’s news brought to you by the team at small-cap broker and advisor Hybridan.
Mark Watson-Mitchell profiles a few of his favourite stocks.
It has been another tough period for Scottish Mortgage, with the trust reporting a 15% loss in the six months ended September compared to a seven percent decline in the FTSE All World index.
